Surgery Clinical Trial
Official title:
The Effect of Lidocaine to Prevent the Development of Chronic Post-Surgical Pain
The study seeks to investigate a safe and inexpensive strategy to reduce persistent
post-surgical pain that can affect up to 60% of patients undergoing surgical procedures.
Hypotheses: Perioperative systemic lidocaine reduces the persistence of chronic pain in
patients undergoing surgical procedures.
After approval from Northwestern University's IRB, female subjects undergoing urologic,
gynecologic or breast surgery will be included in the study. Informed consent will be
obtained from all participants. Subject will be randomized using a computer generated table
of random numbers into two groups: Group L will receive a 1.5 mg/kg bolus of intravenous
lidocaine followed by a 2mg/kg/hr infusion that will be started at the time of surgical
induction and will be discontinued one hour after the end of the surgical procedure. Group P
will receive the same amount of saline in the same fashion. This dose regimen of systemic
lidocaine chosen in the current study has been consistently associated with a reduction of
acute postoperative pain.4 There will be no visual characteristic differences between any of
the infusions studied and they will all be labeled as a study drug. Patients will receive a
standard anesthetic regimen consisting of propofol, fentanyl, succinylcholine, and
sevoflurane. Patients will receive ondansetron 4mg and dexamethasone 4 mg to prevent
postoperative nausea and vomiting. They will also receive 10 mcg/kg of hydromorphone at the
end of surgery to prevent postoperative pain. In the PACU, patients will receive additional
doses of hydromorphone to keep pain <4/10 (on a scale where 0 means no pain and 10 is the
worst pain possible). On PACU discharge, patients will receive a patient-controlled IV
hydromorphone analgesia pump set at 0.2mg IV bolus, no basal infusion and a lockout time of
15 minutes. The intraoperative and postoperative data (pain scores, opioid consumption, side
effects) will be collected by a research assistant blinded to the group allocation). Other
data collection variables include : Preoperative (Age, BMI, ethnicity, comorbidities,
preoperative medication(s), psychiatric disease, pain in the operative area, pain at other
locations), Intraoperative (description of surgical procedure, surgical duration, surgical
procedure on nerve areas, preservation of the nerves in the operative area nerve, indication
for the surgical procedure, intraoperative opioids dose, and Postoperative pain instruments
(evaluation of early pain, twenty four hour opioid consumption, drugs and other treatments
used in the postoperative period.
QOR 40 questionnaire will be completed by the participant at 24 hours after surgery if they
have not been discharged from the hospital. If they have been discharged, the research
assistant will contact the participant by telephone to complete the questionnaire.
Patients will be evaluated for the presence and severity of chronic pain as well as the
quality of life impact of pain at baseline, three and six months after surgery using a
validated instrument in accordance with the IMMPACT recommendations to assess chronic pain
and its impact on the patient's quality of life (Brief pain Inventory).8 To characterize the
chronic pain, both the short form McGill pain questionnaire and the Modified LANNS scale will
be also administered at three and six months.9,10 If there is no response to the 3 month
questionnaire, the subject will be contacted by telephone to complete the questionnaire.
Subjects who are experiencing suicidal ideation will be referred to Northwestern Memorial
Hospital Emergency Department. The primary care surgeon will also be notified by the
principal investigator. Mood will be assessed using the Beck Depression Inventory.14
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT03213314 -
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies
|
N/A | |
| Enrolling by invitation |
NCT05534490 -
Surgery and Functionality in Older Adults
|
N/A | |
| Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
| Terminated |
NCT04612491 -
Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
|
||
| Recruiting |
NCT06397287 -
PROM Project Urology
|
||
| Recruiting |
NCT04444544 -
Quality of Life and High-Risk Abdominal Cancer Surgery
|
||
| Completed |
NCT04204785 -
Noise in the OR at Induction: Patient and Anesthesiologists Perceptions
|
N/A | |
| Completed |
NCT03432429 -
Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
|
||
| Completed |
NCT04176822 -
Designing Animated Movie for Preoperative Period
|
N/A | |
| Recruiting |
NCT05370404 -
Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain:
|
N/A | |
| Not yet recruiting |
NCT05467319 -
Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS
|
Phase 3 | |
| Recruiting |
NCT04602429 -
Children's Acute Surgical Abdomen Programme
|
||
| Completed |
NCT03124901 -
Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor
|
N/A | |
| Completed |
NCT04595695 -
The Effect of Clear Masks in Improving Patient Relationships
|
N/A | |
| Recruiting |
NCT06103136 -
Maestro 1.0 Post-Market Registry
|
||
| Completed |
NCT05346588 -
THRIVE Feasibility Trial
|
Phase 3 | |
| Completed |
NCT04059328 -
Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
|
||
| Recruiting |
NCT03697278 -
Monitoring Postoperative Patient-controlled Analgesia (PCA)
|
N/A |